Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1982-09-13
1985-07-23
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 88, 260112R, A61K 3908, C07G 700
Patent
active
045308330
ABSTRACT:
Mono-specific antibodies for each of toxin A and toxin B of C. difficile are produced and used in an assay for toxin A and toxin B, respectively. Purified toxin A of C. difficile is also produced.
REFERENCES:
Taylor, N., et al., Infect. Immun., vol. 34, pp. 1036-1043, 1981.
Sullivan, N., et al., Infect. Immun., vol. 35, pp. 1032-1040, 1982.
Lyerly, D., et al., Infect. Immun., vol. 35, pp. 1147-1150, 1982.
Chemical Abstracts, vol. 98, Abst. No. 105333n, 1983.
Chemical Abstracts, vol. 95, Abst. No. 36781f, 1981.
Sullivan Nadine M.
Wilkins Tracy D.
Hazel Blondel
Olstein Elliot M.
LandOfFree
Toxins and antibodies of C. difficile does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Toxins and antibodies of C. difficile, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Toxins and antibodies of C. difficile will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-634151